Unbound MEDLINE

Lower facial contouring with botulinum toxin type A. The Journal of craniofacial surgery [J Craniofac Surg] Journal article

 
TitleLower facial contouring with botulinum toxin type A.
Author(s)Tartaro G, Rauso R, Santagata M, Santillo V, Itro A 
InstitutionDepartment of Head and Neck Pathology, Oral Cavity and Audio-Verbal Communication, 2nd University of Naples, Naples, Italy.
SourceJ Craniofac Surg 2008 Nov; 19(6):1613-7.
AbstractThe use of botulinum toxin (BoNT) is well established in medical practice. The application of BoNT extends over many indications such as strabismus, blepharospasm, hemifacial spasm, and others. Another indication for the use of BoNT type A is the masseteric muscle hypertrophy to obtain a lower facial contouring. Authors report the treatment of 5 patients with intramuscular injection of BoNT. A high degree of patient and physician satisfaction was noted after the treatment. Authors concluded that BoNT type A can safely be considered as a noninvasive drug treatment for patients with MMH.
Languageeng
Pub Type(s)Journal Article
PubMed ID19098563
  
Advertise on this site.